MTIP
ETRM

Magee Thomson Investment Partners’s EnteroMedics Inc. ETRM Stock Holding History

Magee Thomson Investment Partners’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3
Closed -$6K – 170
2014
Q2 		$6K Buy
3
+1
+50% +$1.87K ﹤0.01% 129
2014
Q1 		$4K Buy
+2
New +$4.74K ﹤0.01% 147

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Magee Thomson Investment Partners's ETRM Position: Q3 2014 in Review

Magee Thomson Investment Partners sold out of EnteroMedics Inc. (ETRM) in Q3 2014, closing a stake of 3 shares — an estimated $6K sold.

Magee Thomson Investment Partners first reported a position in ETRM in Q1 2014 and held it in 2 quarters. The position peaked at $6K in Q2 2014. 49 funds tracked by Wall St. Rank hold ETRM as of Q3 2014.

  • Magee Thomson Investment Partners reported no remaining EnteroMedics Inc. position as of Q3 2014 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 3 EnteroMedics Inc. shares in Q3 2014, an estimated $6K.
  • Magee Thomson Investment Partners first reported a position in EnteroMedics Inc. in Q1 2014 and held it in 2 quarters.
  • Magee Thomson Investment Partners's EnteroMedics Inc. position peaked at $6K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2014.

Based on Magee Thomson Investment Partners's 13F filing for Q3 2014, filed 5 Nov 2014.